标题
Anti-TNF therapy: past, present and future
作者
关键词
-
出版物
INTERNATIONAL IMMUNOLOGY
Volume 27, Issue 1, Pages 55-62
出版商
Oxford University Press (OUP)
发表日期
2014-11-20
DOI
10.1093/intimm/dxu102
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Similar mortality rates in hip fracture patients over the past 31 years
- (2014) Simran Mundi et al. Acta Orthopaedica
- Targeting fibroblast-like synovial cells at sites of inflammation with peptide targeted liposomes results in inhibition of experimental arthritis
- (2014) A.S. Vanniasinghe et al. CLINICAL IMMUNOLOGY
- Selective Tumor Necrosis Factor Receptor I Blockade Is Antiinflammatory and Reveals Immunoregulatory Role of Tumor Necrosis Factor Receptor II in Collagen-Induced Arthritis
- (2014) Fiona E. McCann et al. Arthritis & Rheumatology
- Unraveling the signaling pathways promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic target
- (2013) L. S. Verjee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis
- (2012) Adam P. Gregory et al. NATURE
- TNF- promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cells
- (2011) G. E. Glass et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Post-transcriptional regulation of α-smooth muscle actin determines the contractile phenotype of Dupuytren's nodular cells
- (2010) Liaquat Suleman Verjee et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Tumor necrosis factor- triggers a cytokine cascade yielding postoperative cognitive decline
- (2010) N. Terrando et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Toll-Like Receptor-2 Mediates Inflammation and Matrix Degradation in Human Atherosclerosis
- (2009) Claudia Monaco et al. CIRCULATION
- Injectable Collagenase Clostridium Histolyticum for Dupuytren's Contracture
- (2009) Lawrence C. Hurst et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study
- (2008) B Combe et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
- (2008) P. Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies
- (2008) E Keystone et al. ANNALS OF THE RHEUMATIC DISEASES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started